NCT04774952 2025-04-15
Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Phase 1 Completed
Revolution Medicines, Inc.
Catalysis SL
Innovent Biologics (Suzhou) Co. Ltd.
Mirai Medical
CDx Diagnostics